Validation of a genotyping method for analysis of TPMT polymorphisms

Area of Science:

• Pharmacogenetics
• Molecular Diagnostics

Background:

• Thiopurine methyltransferase (TPMT) metabolizes thiopurine drugs like azathioprine.
• TPMT gene mutations are linked to reduced enzyme activity and severe side effects, including myelotoxicity.
• TPMT genotyping is essential for identifying patients at risk of drug toxicity.

Purpose of the Study:

• To validate a novel LightSNiP real-time PCR method for TPMT genotyping.
• To compare the LightSNiP method against conventional PCR sequencing for TPMT allele detection.

Main Methods:

• LightSNiP, a real-time PCR assay, was used to detect TPMT*2, *3B, and *3C alleles.
• Genotyping results from LightSNiP were compared with conventional PCR sequencing.
• The study included 111 white adult patients.

Main Results:

• The LightSNiP method showed no discrepancies compared to conventional PCR sequencing for TPMT*2, *3B, and *3C alleles.
• This indicates high concordance between the two genotyping techniques.

Conclusions:

• The LightSNiP method is a valid and reliable tool for TPMT genotyping.
• This real-time PCR approach offers an efficient alternative to sequencing for detecting key TPMT variants.